Kallistatin in blood pressure regulation: Transgenic and somatic gene delivery studies

Trends in Cardiovascular Medicine

Volumn 7, Issue 8, 1997, Pages 307-311

  Chao, Julie ^a   Chao, Lee ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; KALLIKREIN; KALLIKREIN BINDING PROTEIN; KALLISTATIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; BLOOD PRESSURE REGULATION; DOSE RESPONSE; GENE TARGETING; GENETIC LINKAGE; HYPERTENSION; KALLIKREIN KININ SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030689701     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00089-3     Document Type: Review

References (33)

1. Abelous JE, Bardier E: 1909. Les substances hypertensives de l'urine humaine normale. C R Soc Biol 66:511.
2. Bhoola KD, Figueroa CD, Worthy K: 1992. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44:1-80.
3. Chai KX, Chen LM, Chao J, Chao, L: 1993. Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli. J Biol Chem 268:24,498-24,505.
4. Chai KX, Ward DC, Chao J, Chao L: 1994. Molecular cloning, sequence analyses, and chromosomal localization of human kallistatin gene. Genomics 23:370-378.
5. Chai KX, Chen VC, Ni A, Lindpaintner K, Speranza R, Chao L, Chao J: 1997. Molecular cloning and expression of rat kallistatin gene. Biochim Biophys Act (in press).
6. Chao C, Wang C, Liang Y, Chao L, Chao J: 1995. Differential regulation of kallikrein, kininogen and kallikrein-binding protein in hypertensive rats induced by nitric oxide synthesis inhibition. Am J Physiol 271:F78-F86.
7. Chao J, Chao L: 1988. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J Hypertens 6:551-557.
8. Chao J, Chao L: 1995. Biochemistry, regulation and potential function of kallistatin. Biol Chem Hoppe-Seyler 376:705-713.
9. Chao J, Tillman DM, Wang MY, Margolius HS, Chao L: 1986. Identification of a new tissue kallikrein-binding protein. Biochem J 239: 325-331.
10. Chao J, Chai KX, Chen LM, et al.: 1990. Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J Biol Chem 265:16,394-16,401.
11. Chao J, Chen LM, Chai KX, Chao L: 1992. Expression of kallikrein-binding protein and α1-antitrypsin genes in response to sex hormones, growth, inflammation and hypertension. Agents Actions Suppl. 38:174-181.
12. Chao J, Schmaier A, Chen LM, Yang R, Chao L: 1996. Kallistatin, a novel human tissue kallikrein inhibitor: expression in blood cells and abnormal plasma level in human liver disease, sepsis and preeclampsia. J Lab Clin Med 127:612-620.
13. Chao J, Stallone JN, Liang YM, Chen LM, Wang DZ, Chao L: 1997. Kallistatin is a potent new vasodilator. J Clin Invest 100:1-7.
14. Chen LM, Chao L, Mayfield RK, Chao J: 1990. Differential interactions of human kallikrein-binding protein and α1-antitrypsin with human tissue kallikrein. Biochem J 267:79-84.
15. Chen LM, Song Q, Chao L, Chao J: 1995. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int 48:690-697.
16. Chen LM, Ma JX, Liang YM, Chao L, Chao J: 1996. Tissue kallikrein-binding protein reduces blood pressure in transgenic mice. J Biol Chem 271:27,590-27,594.
17. Chen LM, Chao L, and Chao J: 1997a. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats. Hum Gene Ther 8:341-347.
18. Chen LM, Chao L, Chao J: 1997b. Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock. Life Sci (in press).
19. Frey EK, Kraut H: 1928. Ein neues kreislauf-hormon und seine wsirkung. Arch Exp Pathol Pharmakol 133:1-56.
20. Geiger R, Stuckstedte U, Clausnitzer B, Fritz H: 1981. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor). Hoppe Seylers Z Physiol Chem 362:317-325.
21. Lin KF, Chao J, Chao L: 1995. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension 26:847-853.
22. Lindpaintner K, Chai KX, Kreutz R, et al.: 1994. Identification of a major gene locus linked sodium-sensitivity in genetically hypertensive rats. Hypertension 24:387.
23. Ma JX, Yang R, Chao J, Chao L: 1995. Direct kallikrein-binding protein gene injection reverses the hypotensive effect of human kallikrein in transgenic mice. J Biol Chem 270: 451-455.
24. Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J: 1996a. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Experimental Eye Research. 63:19-26.
25. Ma JX, Chao JL, Chao L: 1996b. Identification and characterization of two promoters of rat kallikrein-binding protein gene. Biochim Biophys Acta 1307:285-293.
26. Margolius HS: 1995. Kallikreins and kinins: some unanswered questions about system characteristics and roles in human disease. Hypertension 26:221-229.
27. Mayfield RK, Margolius HS: 1983. Renal kallikrein-kinin system. Am J Nephrol 3:145-155.
28. Wang C, Chao L, Chao J: 1995. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest 95:1710-1716.
29. Wang DZ, Song Q, Chen LM, Chao L, Chao J: 1996. Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland. Am J Physiol 40:F709-F716.
30. Xiong W, Tang CQ, Zhou GX, Chao L, Chao J: 1992. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. J Lab Clin Med 119:514-521.
31. Xiong W, Chao J, Chao L: 1995. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension 25: 715-719.
32. Yang T, Terada Y, Nonoguchi H, Tsujino M, Tomita K, Maromo F: 1994. Distribution of kallikrein-binding protein mRNA in kidneys and differences between SHR and WKY rats. Am J Physiol 267:F325-F330.
33. Zhou GX, Chao L, Chao J: 1992. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. J Biol Chem 267:25,873-25,880.